Navigation Links
Hilleman Laboratories Signs MoU With NICED, ICMR to Develop Shigella Vaccine
Date:3/30/2017

NEW DELHI, March 30, 2017 /PRNewswire/ --

Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, signed a Memorandum of Understanding (MoU) with National Institute of Cholera and Enteric Diseases (NICED), an ICMR organization for further development and commercialization of the Shigella vaccines and other enteric vaccines for diarrheal diseases. This agreement was signed as an effort of Hilleman's mission to make affordable vaccines for the developing world population.

     (Logo: http://mma.prnewswire.com/media/484627/Hilleman_Laboratories_Logo.jpg)

Present at the press conference to announce the collaboration were Dr.Soumya Swaminathan, Director General of ICMR and Secretary, Department of Health Research - Ministry of Health and Family WelfareGovernment of India; Dr Shanta Dutta, Director, NICED and Dr Davinder Gill, Chief Executive Officer, Hilleman Labs.

Addressing the press conference at the signing-in, Dr. Davinder Gill said, "Shigella is the second most fatal organism after Rotavirus that causes severe diarrhea in children with no approved vaccine available at this time. We are pleased at this opportunity to collaborate with NICED and jointly develop Shigella vaccine for a disease whose basic pathology is not yet properly understood. NICED comes with a variety of strengths in research and developing strategies for treatment, prevention and control of enteric infections. This will also be a strategic shift for Hilleman, since till now, our focus has been to optimise existing vaccines and address the gaps in low resource settings."

Dr. Soumya Swaminathan added by saying, "This is a step in a new direction. India has immense potential in clinical research, drug and device manufacturing and we would like to see more of these types of partnerships to happen within the country to realize the 'Make in India' dream."

Dr. Shanta Dutta said, "Vaccines are the most simple, powerful and cost-effective health intervention and an effective public health tool. Our association with Hilleman Labs is in alignment with NICED's mission to identify enteric infections, initiate appropriate multidisciplinary research and develop strategies for treatment, control and prevention of enteric infections. We look forward at this as a strong partnership aspiring to unlock new knowledge behind the enteric disease like shigellosis and to come up with appropriate and effective preventive tool against this disease."

Hilleman Laboratories

Hilleman Laboratories is a first-of-its-kind joint-venture partnership formed between MSD a global research-driven pharmaceutical organization and Wellcome Trust, a global charitable foundation dedicated to human and animal health by supporting the brightest minds.

Contacts:
Geeta Lama
+91-708655058



'/>"/>
SOURCE Hilleman Laboratories
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Invictus MDs AB Laboratories Inc. Provides Cultivation Update under ACMPR
2. Medical Laboratories Stocks Under Scanner -- Organovo, DexCom, Quest Diagnostics, and Alere
3. 2017 US Drugs of Abuse Testing Market: Hospitals, Commercial Laboratories, POC Locations
4. Healthcare Stocks on Investors Radar -- Delcath Systems, Palatin Technologies, AMAG Pharma, and IDEXX Laboratories
5. Medical Laboratories Stocks Under Scanner -- Great Basin Scientific, Biocept, Quintiles IMS, and OpGen
6. Teewinot Life Sciences Corporations Subsidiary, Full Spectrum Laboratories, Ltd., Announced Today: Grant of an Important U.S. Patent with Broad Claims to Biosynthetic Production of Cannabinoids
7. Charleston Laboratories, Inc. Announces Senior Global Regulatory Hire
8. Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Receive Complete Response Letter from FDA for New Drug Application for CL-108 (hydrocodone, acetaminophen, promethazine) Tablets for Oral Use
9. Intraoral Cameras Market Analysis & Trends - End-User (Dental Academic And Research Institutes, Dental Clinics, Dental Laboratories and Forensic Laboratories) - Forecast to 2025
10. Teewinot Life Sciences Irish Subsidiary Full Spectrum Laboratories, Ltd. Secures a New U.S. Patent for Biosynthesis of Cannabinoids
11. Research and Markets - General Surgery Devices Market to Reach $17 Billion by 2024, with Abbott Laboratories, Danaher Corporation & Bio-Rad Labs Dominating
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... July 13, 2017  Centurion Medical Products, a leader in medical ... ® fecal impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are ... help alleviate patient pain while preventing unneeded emergency department admission due ...
(Date:7/12/2017)... Lilly and Company (NYSE: LLY ) has entered ... patent litigation in the U.S. District Court for the Eastern ... ® (tadalafil) unit dose patent. This patent was previously ... the agreement, Cialis exclusivity is now expected to end at ... dose patent for Cialis is valid and infringed by companies ...
(Date:7/11/2017)... July 11, 2017  Sysmex America, Inc., a ... testing equipment as well as middleware information systems ... to make quality assurance easier and more risk ... well known for the innovation that it delivers ... elevates quality assurance processes to a new level ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... July 20, 2017 , ... ... further expand its existing adherence automation lines. The ATP® Mini and InspectRx® ... technology of TCG’s standard products, but at a size and price point that ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... since 2014, top travel insurance solution company VisitorsCoverage Inc. has launched TMQuotes, a ... major international travel insurance products online, under their own brand. The online marketplace ...
(Date:7/20/2017)... ... 2017 , ... A local summer theatre camp is celebrating ... support fine arts programs in Chester County’s Elementary Schools. In late June, students ... , More than 850 people attended the two performances, an increase from ...
(Date:7/20/2017)... (PRWEB) , ... July 19, 2017 , ... Med Tech ... the Minnesota based Health IT business unit of Constellation Inc., a move that will ... established base of operations in St. Louis, the acquisition is expected to help ...
(Date:7/20/2017)... ... July 19, 2017 , ... A July 5th ... weight loss surgery patients who had received a body contouring procedure reported experiencing a ... clinic Beverly Hills Physicians (BHP), which provides both types of procedures, notes that this ...
Breaking Medicine News(10 mins):